(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.18%) $0.801
(-0.32%) $91.87
Live Chart Being Loaded With Signals
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company...
Stats | |
---|---|
Today's Volume | 78 817.00 |
Average Volume | 45 414.00 |
Market Cap | 24.80B |
EPS | $0 ( 2024-02-08 ) |
Next earnings date | ( $0 ) 2024-05-20 |
Last Dividend | $0.141 ( 2021-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 38.60 |
ATR14 | $0.0360 (0.22%) |
Volume Correlation
Terumo Corporation Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Terumo Corporation Correlation - Currency/Commodity
Terumo Corporation Financials
Annual | 2023 |
Revenue: | $820.21B |
Gross Profit: | $417.37B (50.89 %) |
EPS: | $59.50 |
FY | 2023 |
Revenue: | $820.21B |
Gross Profit: | $417.37B (50.89 %) |
EPS: | $59.50 |
FY | 2022 |
Revenue: | $703.30B |
Gross Profit: | $369.34B (52.52 %) |
EPS: | $58.72 |
FY | 2021 |
Revenue: | $613.84B |
Gross Profit: | $326.62B (53.21 %) |
EPS: | $102.33 |
Financial Reports:
No articles found.
Terumo Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.135 | 2021-03-29 |
Last Dividend | $0.141 | 2021-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | $0.277 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.65 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.94 | |
Div. Directional Score | 8.77 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
NKRKY | Ex Dividend Junior | 2023-04-27 | Annually | 0 | 0.00% | |
CUSI | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% | |
TGSGY | Ex Dividend Knight | 2023-08-02 | Quarterly | 0 | 0.00% | |
IDCBY | Ex Dividend Junior | 2023-07-06 | Annually | 0 | 0.00% | |
BCUCY | Ex Dividend Knight | 2023-05-22 | Annually | 0 | 0.00% | |
PKIUF | Ex Dividend Knight | 2023-09-21 | Bi-Monthly | 0 | 0.00% | |
EFGSY | Ex Dividend Knight | 2023-05-11 | Annually | 0 | 0.00% | |
UEPCN | Ex Dividend Knight | 2023-07-20 | Quarterly | 0 | 0.00% | |
KBCSY | Ex Dividend Junior | 2023-05-09 | Annually | 0 | 0.00% | |
BYDDY | Ex Dividend Junior | 2023-06-12 | Sporadic | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.112 | 1.500 | 7.76 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0585 | 1.200 | 8.05 | 9.66 | [0 - 0.3] |
returnOnEquityTTM | 0.0827 | 1.500 | -0.192 | -0.288 | [0.1 - 1] |
payoutRatioTTM | 0.323 | -1.000 | 6.77 | -6.77 | [0 - 1] |
currentRatioTTM | 1.905 | 0.800 | 5.48 | 4.38 | [1 - 3] |
quickRatioTTM | 1.034 | 0.800 | 8.62 | 6.90 | [0.8 - 2.5] |
cashRatioTTM | 0.466 | 1.500 | 8.52 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.134 | -1.500 | 7.77 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 45.48 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.186 | -1.500 | 9.26 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.513 | 1.000 | 4.79 | 4.79 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.146 | 1.000 | 9.08 | 9.08 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.592 | 1.000 | 7.82 | 7.82 | [0.2 - 2] |
assetTurnoverTTM | 0.523 | 0.800 | 9.84 | 7.88 | [0.5 - 2] |
Total Score | 12.60 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 38.97 | 1.000 | 6.16 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0827 | 2.50 | -0.124 | -0.288 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 40.66 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.00418 | 1.500 | 9.90 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 89.97 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.323 | 1.500 | 6.77 | -6.77 | [0 - 1] |
pegRatioTTM | -0.0189 | 1.500 | -3.46 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.151 | 1.000 | 8.72 | 0 | [0.1 - 0.5] |
Total Score | 4.94 |
Terumo Corporation
Terumo Corporation engages in the manufacture and sale of medical products and equipment worldwide. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems, imaging catheters, and others; coils, stents, and intrasaccular devices for treating cerebral aneurysm; embolization systems, aspiration catheters, and clot retrievers for treating ischemic stroke and others; oxygenators, cardio-pulmonary bypass systems, and others; and artificial vascular and stent grafts. The Medical Care Solutions Company segment provides syringes, infusion pumps, syringe pumps, infusion lines, I.V. solutions, peritoneal dialysis fluids, pain management and nutritious food products, adhesion barriers, and others; blood glucose monitoring systems, disposable needles for pen-injector, insulin patch pumps, blood pressure monitors, digital thermometers, and others; and contract manufacturing of prefilled syringes, devices to pharmaceutical companies for use in drug kits, such as prefillable syringes, needles for pharmaceutical packaging business, and others. The Blood and Cell Technologies Company segment offers blood bags, component collection systems, automated blood processing systems, pathogen reduction systems, centrifugal apheresis systems, cell expansion systems, and others. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was incorporated in 1921 and is headquartered in Tokyo, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators